Companies similar to Ionis Pharmaceuticals (IONS)
Health Care · NASDAQ
Ionis Pharmaceuticals (IONS)'s closest peers include Biogen (BIIB), Alnylam Pharmaceuticals (ALNY), ASTRAZENECA PLC (AZN), Sarepta Therapeutics (SRPT) and PTC THERAPEUTICS INC (PTCT). This peer set is drawn from IONS's enriched company profile and is informational only — not financial advice.
Similar companies
-
BiogenBIIBHealth Care
Biogen is a global biotechnology company developing and commercializing therapies across neurology, immunology, and rare genetic disease.
$203.16 (as of 2026-07-21) · market cap $29.7B
-
Alnylam PharmaceuticalsALNYHealth Care
Alnylam is a global leader in RNA interference therapeutics, pioneering a new class of genetic medicines to treat rare and serious diseases.
$271.37 (as of 2026-07-21) · market cap $36.2B
-
ASTRAZENECA PLCAZN
Leading global biopharmaceutical company developing targeted oncology, cardiovascular, and rare disease treatments backed by a strong R&D pipeline.
$169.34 (as of 2026-07-21) · market cap $195.3B
-
Sarepta TherapeuticsSRPTHealth Care
A biopharmaceutical leader in genetic medicine, specializing in innovative RNA-targeted therapies and gene treatments for Duchenne muscular dystrophy and rare…
$16.21 (as of 2026-07-21) · market cap $1.8B
-
PTC THERAPEUTICS INCPTCTHealth Care
PTC Therapeutics develops precision medicines and gene therapies targeting rare genetic disorders and serious diseases, generating revenue from approved…
$78.50 (as of 2026-07-21) · market cap $6.5B
Not quite? Describe exactly what you want →
Peers are drawn from IONS's enriched profile (the same similarity signal the chat uses for "companies like IONS"). See the full profile: Ionis Pharmaceuticals (IONS).
Last updated 2026-07-21.
Informational only — NOT financial advice. Company data is sourced from SEC EDGAR + Finnhub and shown with its as-of date.